ARCHIVES

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Senate Subcommittee Gives NCI 41.397 Billion for FY ‘87

August 8, 1986

White House Order Poses Difficulties For NIH Peer Review

April 2, 1993

NTP Board Okays concept for New In Vitro study Using Oncogenes

May 10, 1985

DD Should Transfer Part of Breast Cancer $$ To NIH r Peer Distribution, Broder Says

December 4, 1992

ACC Survey Preliminary Finding: Three Cancer DRG Categories “Clearly Underpaid Across The Board”

January 25, 1985

Black-White Disparity Seen In End Of Life Treatment

November 27, 2009